Patient21, a Berlin, Germany-based digi-physical healthtech company, raised €100M in Series C funding.
The round was led by Pitango, joined by Bertelsmann Investments and Artian and supported by existing investors Target Global, Piton Capital, PICO Venture Partners and angel investors, including Mario Kohle and Maria Raga. Growth debt from IPF Partners, which constituted a small part of the funding, has been secured to complement the equity raise.
The company intends to use the funds to drive the development of its software platform and expand from Germany into further European markets.
Led by CEO Christopher Muhr and COO Nicolas Hantzsch, Patient21 is a digi-physical healthtech company, which develops a proprietary software platform that covers the entire patient journey creating an integrated patient experience, and reducing administrative burden on healthcare professionals. The proprietary software stack covers every aspect of the patient experience from online booking, digital case history, check-in, diagnosis, treatment planning to clinical quality control.
The company operates 53 outpatient clinics across Germany, handling over 300,000 patients’ visits per year.
Patient21 has already become the fourth provider in dentistry in Germany by number of clinics operated since its inception in 2019.
FinSMEs
22/05/2023